Acquisition momentum Vivo’s acquisition of Infusion Associates signals growth and potential cross-sell opportunities across the infusion therapy network. Approach the combined entity to explore integrated service offerings, referrals, and consolidated purchasing.

Geographic expansion Recent openings in Minnesota and Michigan indicate a growth trajectory and demand for outpatient infusion services beyond core Michigan markets. Prioritize sales outreach to newly established locations for site-level partnerships, referral relationships, and contract opportunities.

Chronic disease focus Specialization in medically prescribed outpatient infusion and injection therapies for chronic conditions presents alignment with payers and health systems seeking cost-effective, ambulatory care. Position services as alternatives to hospitalization and as part of value-based care strategies.

Integrated care model Care delivery involves physicians, advanced practitioners, nurses, and pharmacists, suggesting opportunities to upsell coordination services, pharmacy integration, and pharmacy-benefit management partnerships within a unified infusion program.

Digital and vendor readiness Existing tech stack (Cloudflare, Office 365, Teams, Paychex, etc.) and online presence indicate readiness for partner integrations, patient access enhancements, and joint marketing. Propose enterprise-level tech-enabled service collaborations and streamlined contracting.